These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 26928657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 50years of oral lipid-based formulations: Provenance, progress and future perspectives.
    Feeney OM, Crum MF, McEvoy CL, Trevaskis NL, Williams HD, Pouton CW, Charman WN, Bergström CAS, Porter CJH.
    Adv Drug Deliv Rev; 2016 Jun 01; 101():167-194. PubMed ID: 27089810
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Active intestinal drug absorption and the solubility-permeability interplay.
    Porat D, Dahan A.
    Int J Pharm; 2018 Feb 15; 537(1-2):84-93. PubMed ID: 29102702
    [Abstract] [Full Text] [Related]

  • 12. Selecting oral bioavailability enhancing formulations during drug discovery and development.
    Leucuta SE.
    Expert Opin Drug Discov; 2014 Feb 15; 9(2):139-50. PubMed ID: 24387781
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The solubility-permeability interplay and oral drug formulation design: Two heads are better than one.
    Dahan A, Beig A, Lindley D, Miller JM.
    Adv Drug Deliv Rev; 2016 Jun 01; 101():99-107. PubMed ID: 27129443
    [Abstract] [Full Text] [Related]

  • 17. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A, Hoffman A.
    J Control Release; 2008 Jul 02; 129(1):1-10. PubMed ID: 18499294
    [Abstract] [Full Text] [Related]

  • 18. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM, Beig A, Carr RA, Spence JK, Dahan A.
    Mol Pharm; 2012 Jul 02; 9(7):2009-16. PubMed ID: 22632106
    [Abstract] [Full Text] [Related]

  • 19. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM, Griffin BT.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):617-24. PubMed ID: 18155800
    [Abstract] [Full Text] [Related]

  • 20. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
    Dokoumetzidis A, Kalantzi L, Fotaki N.
    Expert Opin Drug Metab Toxicol; 2007 Aug 17; 3(4):491-505. PubMed ID: 17696801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.